Lucía Rodríguez-Pombo, María José de Castro-López, Paula Sánchez-Pintos, Jose Maria Giraldez-Montero, Patricija Januskaite, Goretti Duran-Piñeiro, M Dolores Bóveda, Carmen Alvarez-Lorenzo, Abdul W Basit, Alvaro Goyanes, Maria L Couce
Rare diseases are infrequent, but together they affect up to 6-10 % of the world's population, mainly children. Patients require precise doses and strict adherence to avoid metabolic or cardiac failure in some cases, which cannot be addressed in a reliable way using pharmaceutical compounding. 3D printing (3DP) is a disruptive technology that allows the real-time personalization of the dose and the modulation of the dosage form to adapt the medicine to the therapeutic needs of each patient. 3D printed chewable medicines containing amino acids (citrulline, isoleucine, valine, and isoleucine and valine combinations) were prepared in a hospital setting, and the efficacy and acceptability were evaluated in comparison to conventional compounded medicines in six children...
April 19, 2024: International Journal of Pharmaceutics